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Abstract The Bardet–Biedl syndrome (BBS) is a signifi-
cant genetic cause of chronic and end-stage renal failure in
children. Despite being a relatively rare recessive condition,
BBS has come to prominence during the past few years
owing to revelations of primary cilia dysfunction underly-
ing pathogenesis. The study of this multi-system disorder,
which includes obesity, cognitive impairment, genito-
urinary tract malformations and limb deformities, is
beginning to reveal insights into several aspects of
mammalian development and organogenesis. Involvement
of BBS proteins in disparate pathways such as the non-
canonical Wnt and Sonic Hedgehog pathways is highlight-
ing their interplay in disease pathogenesis. Here we review
the recent developments in this emerging field, with the
emphasis on the renal component of the syndrome and
potential future directions.
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Overview of Bardet–Biedl syndrome
The unlikely ensemble of signs that the Bardet–Biedl
syndrome presents has bewildered doctors for over a hundred
years. In 1865 Laurence andMoon reported the first case of an
obese, visually impaired girl with intellectual disabilities [1].
This triad of features was extended in the 1920s by two
independent reports by George Bardet and Artur Biedl
describing the additional characteristics of polydactyly and
hypogenitalism [2, 3]. These remain the cardinal features of
Bardet–Biedl syndrome (BBS), but further manifestations of
the disease have since been recognised. Polycystic kidneys
are the most likely cause of premature death from the
syndrome, combined with complications caused by over-
weight, including type II diabetes, hypertension and hyper-
cholesterolaemia [4] (see Table 1 and Fig. 2 for diagnostic
criteria). This review summarises some key recent findings
in BBS research, focusing on the renal components of the
syndrome. In the light of recent revelations we speculate on
the aetiology of several aspects of the syndrome that may lie
beyond the cilium.
Although BBS is considered to be a developmental
disorder, the only clues in utero may be hexadactyly and
hyperechoic kidneys [7]. Birth weight tends to be normal,
but rapid weight gain begins after the first year, probably
due to hyperphagia rather than metabolic abnormalities [8].
Language acquisition may be delayed until the child is
4 years of age. Diagnosis of BBS is often only established
once the vision begins to degrade. Night blindness
manifests when the child is around 8 years and is followed
by loss of peripheral vision, usually progressing to
significant blindness by 15 years [4].
Twelve BBS genes identified
Early linkage studies revealed a high level of heterogeneity,
culminating in the discovery of not one but, so far, 12 genes
(summarised in Table 2). When mutated, any of these genes
can cause the plethora of BBS features. As there appears to
be no correlation between genotype and phenotype, it has
been hypothesised that the different BBS proteins are
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functioning in a common cellular process [9]. In 2003
Ansley et al. proposed that BBS was caused by a
dysfunction of the cilium and its associated basal body, an
organelle derived from the centriole acting as a nucleation
site for ciliary axonemal microtubules [10]. They discov-
ered BBS8 and showed that its protein localises to the
centrosome and basal body. BBS8 interacts with peri-
centriolar material 1 (PCM1), a protein important for
ciliogenesis. Further, in the nematode C. elegans, bbs8 is
regulated by the transcription factor daf-19 (an RFX-type
transcription factor), a regulator of genes involved in
ciliogenesis and transport [10].
Since this initial association of BBS8 with the basal
body, putative roles for other BBS proteins are being
established. These are summarised in Table 2. BBS1, 2, 4,
5, 6, and 8 all localise to the basal body and peri-centriolar
region. In C. elegans BBS7 and BBS8 localise to the base
of the cilium and are transported along the axoneme of
sensory neurons [17]. BBS4 functions in the microtubule
apparatus and interacts with subunits of dynactin, implying
a role in retrograde intraflagellar transport (IFT) [14]. BBS6,
10, and 12 are likely chaperonins, which may facilitate
protein folding and together account for one third of all
cases [21]. Why mutations in chaperonins should cause the
features of BBS is, as yet, unknown, but it could be due to
aberrant folding of proteins essential for IFT or ciliogenesis.
Aetiology lies in the cilium
Cilia are ancient eukaryotic organelles that project from the
cell surface. They fall into two classes: motile and immotile.
Motile cilia consist of an outer ring of nine doublets of
microtubules surrounding an inner pair—the “9+2” arrange-
ment. Radial spokes link the outer ring doublets to the inner
doublet, and dynein motor proteins, spanning adjacent outer
doublets, power the beating of the cilium. This beating
motion is used to drive fluid flow in the respiratory tract and
oviduct, and propels spermatozoa.





Rod-cone dystrophy 93% Other ocular defects included: astigmatism, strabismus, cataracts, colour
blindness, macular oedema and degeneration, and optic atrophy
Post-axial polydactyly 69% Present on all four limbs in 21% of patients, only hands in 9% and only feet in
21%. Brachydactyly present in 46% and syndactyly in 9% of patients
Truncal obesity 72% Mean BMI in males was 31.5 kg/m2, in females it was 36.6 kg/m2
Hypogonadism 98% Males had hypogenitalism and 8% had maldescended testes. Most women
reported irregular menstrual cycles
Renal anomalies 24% (only 52% of patients had
undergone renal examination)
Renal parenchymal cysts (10%), calyceal clubbing (10%), foetal lobulation
(12%), scarring (12%), dysplastic kidneys (5%), unilateral agenesis (4%), renal
calculi (2%), vesicoureteric reflux (9%), bladder obstruction (4%),
hydronephrosis (4%), horseshoe kidney (2%), ectopic kidney (2%)
Secondary features
Speech disorder/delay 54%
Developmental delay 50% 52% showed delay in walking of up to 1 year, speech delayed by up to 2 years in
47%, delay in pubescence in 31% (all males)
Behaviour 33% Emotional immaturity, outbursts, disinhibition, depression and lack of social
dominance, obsessive compulsive behaviour
Ataxia/imbalance 40% Abnormal gait reported in 33% of patients (see [5])
Diabetes mellitus 6%
Congenital heart defects 7% Included: aortic stenosis, patent ductus arteriosis, cardiomyopathy
Liver disease Hepatic fibrosis
Hearing loss 21% Predominantly conductive but some sensorineural
Facial features Deep-set eyes, hypertelorism, long philtrum, thin upper lip, anteverted nares,
prominent forehead with male early-onset balding
Situs inversus Unknown See [6]
Hirschprung disease Unknown See [6]
Polyuria/polydipsia May be present in the absence of renal abnormality
Dental crowding Also includes: high arched palate, hypodontia, small roots
Anosmia ~ 60% See [11]
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The features of BBS do not, in the main, appear to
reflect a defect in motile cilia (except for aflagellate
spermatozoa). Rather, it seems that the immotile sensory
(also called primary) cilia are predominantly affected. These
consist of a “9+0” arrangement of microtubule doublets and
lack the central microtubule pair present in motile cilia.
Until recently, primary cilia were considered to be evolu-
tionary vestiges, with no obvious function. Now their role in
vertebrate physiology is finally being elucidated; many key
signalling pathways rely on the cilium for their function. The
list of molecular pathways with key components localising to
the primary cilium includes: PDGFRα growth factor
signalling [22], hedgehog signalling [23], epidermal growth
factor signalling [24], and 5-HT6 serotonin signalling [25].
See Marshall and Nonaka (2006) for a more comprehensive
list of cilia-dependent signalling pathways [26]. The study
of BBS is improving our understanding of the importance
and complexity of these organelles in development and
homoeostasis.
It is now thought that BBS proteins participate in IFT
[17, 27]. Because cilia lack ribosomes, all proteins involved
in their construction and function must first be imported
and then shuttled along the ciliary axoneme by a raft of
proteins [9]. Cargo bound for the distal end of the cilium is
loaded in the cytoplasm at the transition zone at the base of
the cilium. Anterograde transport is facilitated by the
microtubule motor protein kinesin-2. Retrograde transport
back to the cytoplasm deploys the dynein–dynactin motor
complex. See Blacque and Leroux for a detailed review of
the roles of BBS proteins in IFT [28].
Some BBS proteins are thought to function as adaptors,
helping to load cargo proteins at the proximal cytoplasmic
end for carriage to the distal tip [17]. BBS proteins are also
thought to be required for retrograde transport, where
proteins are shuttled back to the cytoplasm for recycling.
Figure 1 shows how the IFT processes are coordinated in
the cilium. Mutations in a BBS gene reduce or abolish their
protein function, disrupting IFT. This has been demonstrat-
ed in C. elegans, where abrogation of bbs7 or bbs8 both
reduces the length of cilia in neurons (structure) and
disrupts IFT machinery, leading to improper transport of
Table 2 BBS genes identified so far (IFT intraflagellar transport)
Gene Method of discovery Chromosomal
location
Cellular localisaiton Domains Putative function Reference
BBS1 Linkage analysis 11q13 Basal body/cilium None Cilia function [11]
BBS2 Positional cloning 16q21 Basal body/cilium None Cilia function/
flagellum formation
[12]
BBS3/ARL6 Linkage analysis 3p12-q13 Basal body/cilium GTP-binding Vesicle trafficking [13]
BBS4 Positional cloning 15q23 Pericentriolar/basal body TPR/PilF Microtubule transport [14]
BBS5 Comparative genomics 2q31 Basal body/cilium DM16 DUF1448 Cilia function/
flagellum formation
[15]
BBS6/MKKS Mutation analysis 20p12 Basal body/cilium TCP1 chaperonin Cilia function/
flagellum formation
[16]
BBS7 Similarity to BBS2 4q32 Basal body/cilium TPR/PilF IFT particle assembly [17]
BBS8/TTC8 Similarity to BBS4 14q31 Basal body/cilium TPR/PilF IFT particle assembly [17]
BBS9/B1 Homozygosity mapping
with SNP arrays






BBS10 SNP arrays 12q21.2 Unknown TCP1 chaperonin Unknown [19]
BBS11/
TRIM32 SNP arrays 9q31-34.1 Unknown RING WD40 NHL
Barmotin B-Box
E3 ubiquitin ligase [20]
BBS12 SNP arrays 4q27 Unknown Type II chaperonin [21]
Fig. 1 Putative pathomechanism for renal cystic hyperplasia in BBS.
Top left Urine flow through the kidney tubule causes an influx of Ca2+
ions through polycystin 2 (PC2), while polycystin 1 (PC1) anchors the
transcriptional complex of P100 and STAT6 in the cilium. Concur-
rently, inversin is translocated to the nucleus, where it targets
cytoplasmic Dishevelled for destruction, activating the non-canonical
pathway and causing cells to differentiate. The ciliary localisation of
PC1/2 and inversin may be dependent on BBS proteins. Top right
Absence of urine flow reduces Ca2+ influx and causes release of P100
and STAT6, allowing them to enter the nucleus to activate transcrip-
tion. It also prevents translocation of inversin to the cytoplasm,
maintaining the cytoplasmic pool of Dishevelled, which activates the
canonical Wnt pathway and causes proliferation. Bottom left A lack of
BBS protein function may inhibit proper transport of PC1/2 to the
distal tip of the cilium and also prevent translocation of inversin to the
cytoplasm. This would cause inappropriate activation of STAT6 target
and maintenance of cytoplasmic Dishevelled, leading to unregulated
cell proliferation. Additionally, lack of BBS protein function could
disturb planar cell polarity (PCP). The combination of disorganised
cell polarity and cell division could cause the various abnormalities
seen in BBS

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kinesin and other IFT components along the cilium
(function) [17].
Because BBS proteins are not absolutely required for
ciliary function, mutations in BBS genes do not cause as
dramatic an effect as mutations in core IFT proteins such as
Kif3a, which die at 10 days after fertilisation [29]. As such,
the clinical phenotypes of BBS mutants are less severe than
one might expect if IFT were completely abrogated. Some
BBS features can be readily attributed to deficient IFT:
retinitis pigmentosa (RP) can result from transport defects
in the connecting cilium of the rod and cone cells in the
retina, leading to progressive degeneration of the photo-
receptors [30]. Figure 2 summarises these features. Anos-
mia is common amongst patients, owing to flaws in
olfactory cilia [11]. Infertility has been reported in Bbs null
mice, where immotility was attributed to failure of the
spermatozoa flagella to develop [31]. Some BBS patients
have situs inversus, a complete reversal of visceral
laterality, arising from defective cilia in the early embryonic
node. Perhaps the best characterised feature of a presumed
‘ciliopathy’ is the cystic kidneys, with their aetiology in
aberrant ciliary function.
Renal disease is a major cause of mortality in BBS
Beales et al. (1999) reported imaging 59 BBS patients and
found that 46% had abnormal renal structure but only 5%
had functional impairment at the time of scanning [4].
Large, hyperechoic kidneys can be detected prenatally by
ultrasound but are not necessarily a predictor of subsequent
dysfunction [7]. Examples of renal histopathology observed
in BBS patients are shown in Fig. 3.
Two reports in the 1970s described seven patients with
cystic spaces communicating with collecting ducts [32, 33].
O’Dea (1996) conducted a prospective cohort study on 38
patients in Newfoundland, where the disease is ten-times
more prevalent than in mainland Europe or America due to
founder effects [34]. They found that 96% of patients had
foetal lobulation, calyceal cysts, diverticula, or clubbing.
Twenty-five percent of patients suffered functional impair-
ment, fatally in two patients with end-stage renal disease.
Another patient died from metastatic renal cancer.
Beales and colleagues documented an excess of rela-
tively early-onset renal cell carcinomas in obligate carriers
of BBS mutations. Furthermore, they detected loss of
heterozygosity in tumour sections at several BBS loci
[35]. Ersoy et al. (2005) reported a 20-year-old patient who
had undergone renal transplantation who then developed
primary central nervous system lymphoma. They suggested
that BBS patients should be carefully monitored for
developing malignancies [36].
In a cohort of 20 patients in Newfoundland, Harnett and
colleagues identified three with end-stage renal failure [37].
Fourteen (70%) patients could not concentrate urine above
750 mosmol/kg body weight, even after vasopressin
treatment. Upon ammonium chloride administration, uri-
nary pH fell in only 13 patients (65%). Structural
abnormalities tend to be common, with varying degrees of
functional impairment. Alton and McDonald asserted that
30% of BBS patients die from uraemia [32]. Chronic renal
dialysis, or transplantation, has been the only successful
mode of managing these problems for most patients.
Langer and colleagues (2005) presented details of a 57-
year-old patient who had undergone cadaveric kidney
transplantation. Despite developing subsequent pneumonia,
cytomegalovirus and scabies infections post-operatively, he
was fully rehabilitated within 18 months [38].
Currently, in our own cohort, approximately 10% of BBS
patients have undergone transplantation (unpublished data).
An analysis of the long-term outcome of renal transplantation
in BBS is underway, but initial observations suggest that
children manage very well in the immediate-to-medium post-
operative period (unpublished data). Modern steroid-sparing,
anti-rejection regimens should be implemented to optimise
glycaemic control and avoid exacerbation of obesity.
Ciliary origins of kidney disease in BBS
Renal abnormality in BBS is thought to arise as a direct
result of compromised cilia function, although this has yet
Fig. 2 Summary diagram of the major features of BBS. Diagram of
major features of BBS. Features directly attributable to defects in
ciliary function are marked in bold
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to be proven. The origin of this hypothesis lies in the oak
ridge polycystic kidney disease (or pkd) mouse mutant,
which has dilated proximal tubules and cysts, and its cilia
are short and poorly formed [39]. The mutation was
mapped to the gene encoding polaris, a protein required
for assembly of renal cilia [40]. Mutations in the PKHD1
gene cause autosomal recessive polycystic kidney disease
(ARPKD). The protein product, polyductin, co-localises
with polycystin 2 at the base of the cilium [41].
In the nephron, cilia projecting into the lumen from the
apical surface of epithelial cells bend in response to urine
flow. The degree of bending is directly related to the fluid
pressure and causes the opening of calcium channels in the
cilium. The influx of calcium ions is proportional to the
flow and activates intracellular signalling pathways thought
to regulate the cell’s decision either to proliferate or
differentiate. These calcium channels are formed by a
complex of polycystin 1 and polycystin 2 (PC1 and PC2),
encoded by the PKD1 and PKD2 genes, respectively, which
cause autosomal dominant polycystic kidney disease
(ADPKD) when mutated [42]. PC1 binds to the transcrip-
tion factor STAT6 and its co-factor p100. Upon mechanical
shearing caused by urine flow, PC1 disassociates from
STAT6, which travels down the cilium to enter the nucleus
where it activates target genes [43]. It remains to be
discovered whether BBS proteins are involved in the
transport and/or localisation of these ciliary proteins.
Wnt signalling during kidney development
may be regulated at the cilium
Recent evidence is emerging of additional regulatory roles
for the cilium. It seems that the cilium may provide a
regulatory switch between the canonical and non-canonical
Wnt pathways [44]. In the Wnt pathway, diffusible extra-
cellular Wnt ligands bind to their respective membrane-
bound Frizzled receptors, leading to the activation of
Fig. 3 Examples of renal histo-
pathology in BBS patients.
a, b Low and high power
micrographs showing tubular
dilatation in a biopsy from
a BBS patient’s kidney (Histo-
pathological sections courtesy
of Dr. Neil Sebire, Great
Ormond Street Hospital).
c Fundoscopy showing retinitis
pigmentosa with cataract.
d Abdominal CT scan docu-
menting cystic kidneys
(arrowed). e, f Post-axial poly-
dactyly in a hand and foot from
the same child with BBS
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intracellular Dishevelled. If this then activates β-catenin,
the canonical pathway is effected and is associated with re-
entry into the cell cycle and proliferation. This pathway is
required for branching morphogenesis during embryonic
kidney development. Canonical Wnt signalling is dysregu-
lated in Invs mice kidneys, which have a mutation in the
gene encoding the ciliary protein inversin. In humans this
gene (NPHP2) causes nephronophthisis (the most common
autosomal recessive cause of early-onset renal failure) type
II when mutated, which comprises interstitial cell infiltra-
tion, with fibrosis, and duct proliferation with cyst
development [45]. Interestingly, the kidneys are massively
enlarged in NPHP2 mutated mice and patients. Inversin is
activated by tubular fluid flow and targets Dishevelled for
destruction, inhibiting the canonical Wnt pathway and
driving cells down the non-canonical Wnt or PCP pathway
towards differentiation and polarisation throughout the
plane of the tubular epithelium.
In support of this hypothesis, we demonstrated that BBS
proteins are involved in the PCP pathway. Of Bbs4 null
mice, 14% display anterior neural tube defects indicative of
PCP dysfunction [30]. In adulthood, null mice have
disorientated stereociliary bundles on the outer hair cells
of the cochlea, and mice heterozygous for both Looptail
(also known as Vangl2, a “core” PCP gene) and bbs4 have
phenotypes reminiscent of PCP mutants, whilst both single
heterozygotes are normal. Confirmation of the interaction
was made in zebrafish by the injection of a bbs4
morpholino on a PCP mutant background and observing
enhancement of the PCP phenotype.
A subsequent study by Fischer and colleagues suggested
that this interaction may have implications for BBS-related
cystogenesis. They measured the mitotic orientation of cells
taken from the kidney tubules of a rat model of polycystic
kidney disease and found them to be significantly disori-
entated [46]. They attributed this to mis-expression of
polyductin (also called fibrocystin), a ciliary membrane
protein mutated in ARPKD. As mitotic spindle orientation
is regulated by the PCP pathway, aberrations caused by
BBS protein dysfunction could cause similar mitotic defects
in BBS kidneys. These results point to a need for
hyperplasia caused by overactivity of the canonical Wnt
pathway, combined with concomitant defects in planar cell
polarisation.
BBS proteins in renal pathogenesis
So far, the precise role of BBS proteins in renal pathogenesis
is unclear. It is possible that BBS proteins are involved in
the transport of proteins such as the polycystin ion channels
and polaris to the distal end of the cilium, where they
function as components of the sensory apparatus.
It is also possible that BBS proteins are somehow
regulating the function of inversin, which, in turn, is
involved in the selection of canonical versus non-canonical
Wnt pathways. If BBS proteins are absent, inversin
function may be compromised, with the balance shifted in
favour of the canonical pathway and promoting cystic
hyperplasia. Disrupted PCP activity could be associated
with a disordered renal epithelium. This, combined with a
concomitant boost to canonical Wnt signalling, might
explain why some BBS patients show complex renal
involvement; such as mesangial cell proliferation, cystic
dilation of tubules, and corticomedullary cysts [47].
The ciliary plexus
It is emerging that the cilium is indispensable for certain
key developmental signalling cascades. It is now becoming
clear that many discrete pathways converge at, or are
regulated by, the cilium. Park et al. recently showed that
defects in the PCP proteins Inturned and Fuzzy cause
defects in ciliogenesis, with concomitant effects on Sonic
Hedgehog (Shh) signalling [48].
Another ciliopathy, oro-facial digital type I (OFD1),
shares some cardinal features with BBS, notably cystic
kidneys, polydactyly and craniofacial dysmorphology.
Ferrante et al. (2006) showed that when mutated this
protein causes misregulation of downstream Shh pathway
targets in the neural tube [49]. In the developing limb the
expression patterns of Gli3 and Patched1, direct Shh targets
are unaltered; whilst various Hox genes essential for digital
patterning are disrupted. This does not indicate that Gli3
function is unimpaired—Shh patterning depends on the
balance between Gli3’s active and repressive forms, not the
overall level of Gli3 transcript. Several other studies have
shown that defects in ciliary transport cause an imbalance
between active and repressive forms of Gli3, particularly
when exposed to Shh protein [50–52].
BBS patients have several hallmarks of defective Shh
signalling, polydactyly being the most obvious amongst
them. Additionally, many patients have agenesis or hypo-
plasia of the corpus callosum, and a single central incisor,
both elements of the holoprosencephaly spectrum (personal
observations). It is perplexing why ciliopathies such as
BBS, Meckel syndrome, and OFD show features of sonic
abnormalities, whilst others, such as polycystic kidney
disease (PKD) and Senior–Loken syndrome (nephronoph-
thisis with retinal degeneration) do not.
Support for the involvement of the cilium in regulating
both Shh and PCP pathways in development was recently
demonstrated by Park and colleagues [48]. It was also
recently shown that the Gli transcription factors which act
downstream of Shh localise to the cilium too, and require
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IFT for their processing and transcriptional activity [23].
Interruption of the activity of Gli3 represses the activation
of target genes responsible for renal morphogenesis (such
as Pax2 and Sall1) and results in decreased branching
morphogenesis and dilated tubules [53]. Together, these
observations may help account for some of the renal tissue
abnormalities in BBS.
If BBS proteins are essential for all the above-mentioned
signalling pathways and ciliary processes, one would
expect the clinical phenotype to represent full loss of all
involved molecules. However, BBS proteins implicated in
IFT seem to be partially dispensable. In C. elegans, knock-
out of BBS7 and BBS8 destabilises transport of IFT
complexes but does not abrogate function altogether [54].
Using microtubule gliding assays, Pan et al. recently
proposed that BBS7 and BBS8 act as a molecular bridge,
holding the IFT particle complexes A and B together [55].
This holding force seems to be necessary to coordinate
transport along the distal-most portion of the cilium. A lack
of BBS protein function could result in disorganised
shuttling of proteins whose distal localisation in the cilium
is critical for proper function. Proteins transported in this
way may include the polycystins and sonic hedgehog
pathway components such as smoothened and Gli.
Not all cardinal features can be attributed to the cilium
Ciliary dysfunction currently fails to explain, directly,
hypogenitalism, polydactyly, mental retardation, or obesity
in BBS. Nonetheless, we can postulate several mechanisms.
For example, development of the genitalia and gonads is
partly controlled by Shh and bone morphogenetic protein 4
(BMP4) [56]. It is possible that misregulation of the Shh
pathway is partly responsible, in combination with endo-
crine malfunction.
Post-axial polydactyly is present in 70% of patients. It
is known that cells of the developing limb bud, in both
ectoderm and mesenchyme, are ciliated [23]. Along with
the known reliance of the Shh pathway on cilia, it is
tempting to speculate that aberrant Shh signalling in the
limb bud is the cause of the limb deformities seen in BBS.
Post-axial polydactyly is also a primary feature of
Pallister–Hall syndrome, a condition caused by a mutation
in Gli3 [57].
The aetiology of obesity in BBS is more problematic
although we do know that patients’ resting metabolic rate is
normal [8]. Anecdotal reports hint that appetites are
difficult to satiate, implicating a defect in the satiety centre
of the hypothalamus. Like IFT, fast-axonal transport (FAT)
is microtubular based and relies on dynein motors [58].
BBS proteins could play a part in transducing information
about the satiety level to the neuronal cell bodies. However,
there are no published data supporting a role for BBS
proteins in FAT—as such, this is highly speculative. In C.
elegans it has been shown that BBS proteins function in
ciliated neurons that sense external and internal nutrient
levels. bbs1 mutants act synergistically to enhance accu-
mulation of lipids in a C. elegans mutant with impaired β-
oxidation of fatty acids [59].
Despite progress in the identification of pathways
affected in BBS, it is proving difficult to recognise the
point of interaction and, in particular, the components at
fault. Nonetheless, it will be important to determine these
factors, as they may reveal therapeutic targets. For example,
two other centrosomally localised proteins—tuberose scle-
rosis 1 and tuberose sclerosis 2 (TSC1 and TSC2)—cause
renal cysts when their genes are mutated. As both proteins
inhibit mTOR, a kinase controlling cell proliferation, it is
possible to reduce cyst growth by treatment with the mTOR
inhibitor rapamycin. Furthermore, it has been shown that
the mTOR pathway is regulated by polycystin 1 and that
ADPKD patients’ cysts can be ameliorated by rapamycin
treatment [60]. Determining if BBS proteins impinge on
these pathways in the kidney may provide a remedy that is
already well characterised.
Beyond the cilium?
Unexpected new BBS genes (BBS9-12) are being discov-
ered that do not show any intuitive relationship with the
cilium or IFT. It is, therefore, likely that BBS proteins
have extra-ciliary roles. Recently identified BBS genes
include BBS9 (also called B1), a parathyroid hormone-
responsive protein [18]. BBS10 and BBS12 show similarity
to BBS6, and are likely to encode chaperonins with the
potential to fold nascent proteins. BBS10 is a major
pathogenic locus, accounting for 20% of cases [19]. It
has been suggested that BBS6, BBS10, and BBS12 may act
redundantly [21].
BBS11 (also called TRIM32) mutations have been
identified only in a single consanguineous Bedouin family
[20]. It encodes an E3 ubiquitin ligase and may be involved
in protein degradation. Interestingly, TRIM32 has recently
been shown to interact with a protein important for the
sumoylation pathway; Piasy [61]. Whilst ubiquitination
degrades proteins, sumoylation stabilises them. BBS11 may
be involved in the regulation of the stability and lifetime of
proteins associated with the basal body and IFT. Subcellular
localisation for these newly discovered proteins is uncon-
firmed at present, and their function in wild type organisms
has yet to be elucidated.
So far, we know that the PCP, the Shh, and, possibly, the
canonical Wnt (via inversin) pathways rely, at least in part,
on the cilium for their function and are intersected by the
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BBS proteins. The future direction of research in this field
will involve the precise definition of the molecules that are
being regulated by BBS protein malfunction, how this
impacts on their downstream effectors, and whether this
knowledge could lead to any therapeutic intervention.
We must determine why BBS proteins with different
functions produce a syndrome with such a consistent
phenotype. Conversely, why is it that individuals with the
same mutations display such variable phenotypes? Steps
towards answering this question were made by the recent
discovery of a novel gene, MGC1203, which contributes
epistatically to BBS mutations and can enhance the
phenotype, at least in zebrafish embryos [62]. The
combined input of epistatic and mechanistic studies,
derived from multiple animal models, should bring us
closer to understanding this complex disease.
Conclusion
BBS is a rare pleiotropic syndrome, the study of which has
been both challenging and informative well beyond the
scope of the disease itself. So far, the cilium has been held
responsible for the bulk of the pathology, but the precise
mechanisms and pathways involved are only just being
revealed. The PCP and, potentially, sonic hedgehog path-
ways may contribute, in some part, to our understanding of
these problems. The biology of polycystic kidney disease is
in accord with our current understanding of BBS and may
explain the associated renal dysgenesis. In turn, this is
likely to involve imbalanced Wnt signalling, but further
direct functional evidence is required.
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